Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers
Phase of Trial: Phase III
Latest Information Update: 13 Feb 2019
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary) ; Haemophilus vaccines; Hepatitis B vaccine; Measles mumps and rubella virus vaccine; Pneumococcal vaccine; Rotavirus vaccine; Varicella vaccines
- Indications Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections
- Focus Pharmacodynamics; Registrational
- Sponsors sanofi pasteur
- 29 Nov 2018 Planned End Date changed from 1 Jun 2020 to 1 Jul 2020.
- 29 Nov 2018 Planned primary completion date changed from 1 Jun 2020 to 1 Jul 2020.
- 15 Oct 2018 Status changed from not yet recruiting to recruiting.